Community I-STAR Mozambique: Community Implementation of SBIRT using Technology for Alcohol use Reduction in Mozambique

莫桑比克社区 I-STAR:在莫桑比克使用减少酒精使用技术社区实施 SBIRT

基本信息

项目摘要

Hazardous drinking (HD) is a major public health burden worldwide with significant morbidity and mortality. The prevention and treatment gap associated with this global burden requires that efficacious interventions be scaled-up, leveraging existing platforms and participation of policy makers ready to apply and sustain evidence-informed policies over time. To reduce HD, the WHO recommends using Screening, Brief Intervention, Referral to Treatment (SBIRT) and the mental health Gap Action Programme guidelines (mhGAP). As low- and middle-income countries (LMIC) embrace SBIRT and mhGAP for community-based HD services (HDS), a main scale-up challenge is ensuring effectiveness, fidelity, and sustainability of services. Mobile health technology (mHealth), such as the mSBIRT app developed by members of our team, is a promising tool for widespread cost-effective delivery of evidence-based HDS by community health workers (CHWs) because of its potential to increase fidelity, effectiveness, and sustainability. The proposed project, Community I-STAR (Implementation of SBIRT using Technology for Alcohol use Reduction) Mozambique, will leverage the following existing Mozambique Ministry of Health (MoH) programs: (1) a task-shifting strategy training psychiatric technicians (PsyTs) to use the mhGAP; (2) the WHO-funded epilepsy community program delivered by CHWs; and (3) an mHealth program for malaria, pneumonia, and diarrhea (inSCALE - Innovations at Scale for Community Access and Lasting Effects). These currently operating programs set the stage for the use of mSBIRT by CHWs to deliver community HDS in Mozambique and generate policy for scale-up of government-funded community HDS harnessing existing human resources. Community I-STAR Mozambique comprises three phases: 1) mSBIRT adaptation, 2) a cluster-randomized trial, and 3) scale-up of the most cost-effective intervention. After a formative phase to adapt mSBIRT to Mozambique’s context/culture, we will conduct a 2- year, cluster-randomized, hybrid effectiveness-implementation type 2 trial in 12 districts: 6 districts randomized to receive mSBIRT and 6 to an SBIRT Conventional Training and Supervision strategy (SBIRT-CTS), with both arms delivered by CHWs. The arm showing higher cost-effectiveness in the 2-year trial will be scaled up to the other 6 districts for 12 “cross-over” months. Throughout the trial and the “cross-over” scale-up, qualitative and process data will complement quantitative assessments to examine implementation, sustainability, and scale-up. Our approach redefines work roles without requiring new human resources, and it comports with the MoH’s commitment to implementing HDS. We will use evidence-based practices (SBIRT) to a) build capacity for complete task-shifting of sustainable community-HDS practices; and b) use implementation tools to examine implementation and effectiveness of two SBIRT delivery strategies followed by evaluation of scale-up of the most cost-effective strategy. Community I-STAR Mozambique will scale-up a cost-effective, sustainable program and inform policy applicable to Mozambique and other LMICs.
危险性饮酒(HD)是世界范围内的一个主要公共卫生负担,具有显著的发病率和死亡率。的 与这一全球负担相关的预防和治疗差距要求采取有效的干预措施, 扩大规模,利用现有平台,并让决策者参与,随时准备应用和维持 随着时间的推移,以证据为依据的政策。为了减少HD,世卫组织建议使用筛查, 干预,转诊治疗(SBIRT)和心理健康差距行动计划指南(mhGAP)。 随着低收入和中等收入国家(LMIC)采用SBIRT和mhGAP进行社区HD服务, (HDS)因此,扩大规模的一个主要挑战是确保服务的有效性、忠实性和可持续性。移动的健康 技术(mHealth),如我们团队成员开发的mSBIRT应用程序,是一个很有前途的工具, 社区卫生工作者(CHW)广泛提供循证HDS的成本效益,因为其 提高忠诚度、有效性和可持续性的潜力。项目名称:Community I-STAR (利用减少酒精使用技术实施SBIRT)莫桑比克将利用以下措施: 莫桑比克卫生部现有的方案:(1)任务转移战略, (2)由CHW提供的WHO资助的癫痫社区计划; 以及(3)针对疟疾、肺炎和腹泻的移动健康计划(inSCALE -大规模创新, 社区访问和持久的影响)。这些当前运行的程序为mSBIRT的使用奠定了基础 由社区卫生工作者在莫桑比克提供社区人道主义发展服务,并制定扩大政府资助的 社区HDS利用现有的人力资源。莫桑比克I-STAR社区由三个 阶段:1)mSBIRT适应,2)群集随机试验,3)最具成本效益的 干预在使mSBIRT适应莫桑比克的背景/文化的形成阶段之后,我们将进行2- 在12个地区进行的为期1年的整群随机、混合有效性-实施2型试验:6个地区随机化 接受mSBIRT和6到SBIRT常规培训和监督战略(SBIRT-CTS), 社区卫生工作者提供的武器。在2年试验中显示出较高成本效益的手臂将扩大到 其他6个地区的12个“交叉”月。在整个试验和“交叉”放大过程中, 进程数据将补充定量评估,以审查执行情况、可持续性和扩大规模。 我们的方法重新定义了工作角色,而不需要新的人力资源,它符合卫生部的 致力于实施HDS。我们将使用循证实践(SBIRT)来a)建立以下能力: 完成可持续社区HDS实践的任务转移;以及B)使用实施工具来检查 评估两项SBIRT交付战略的实施情况和有效性,然后评估最大规模的 成本效益战略。莫桑比克社区I-STAR将扩大一个具有成本效益的可持续计划, 适用于莫桑比克和其他中低收入国家知情政策。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MILTON L WAINBERG其他文献

MILTON L WAINBERG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MILTON L WAINBERG', 18)}}的其他基金

PRIDE SSA - Partnerships in Research to Implement and Disseminate Sustainable and Scalable Evidence Based Practices in sub-Saharan Africa
PRIDE SSA - 在撒哈拉以南非洲实施和传播可持续和可扩展的循证实践的研究伙伴关系
  • 批准号:
    9769439
  • 财政年份:
    2018
  • 资助金额:
    $ 64.18万
  • 项目类别:
Community I-STAR Mozambique: Community Implementation of SBIRT using Technology for Alcohol use Reduction in Mozambique
莫桑比克社区 I-STAR:在莫桑比克使用减少酒精使用技术社区实施 SBIRT
  • 批准号:
    10687646
  • 财政年份:
    2018
  • 资助金额:
    $ 64.18万
  • 项目类别:
Community I-STAR Mozambique: Community Implementation of SBIRT using Technology for Alcohol use Reduction in Mozambique
莫桑比克社区 I-STAR:在莫桑比克使用减少酒精使用技术社区实施 SBIRT
  • 批准号:
    9661898
  • 财政年份:
    2018
  • 资助金额:
    $ 64.18万
  • 项目类别:
Community I-STAR Mozambique: Community Implementation of SBIRT using Technology for Alcohol use Reduction in Mozambique
莫桑比克社区 I-STAR:在莫桑比克使用减少酒精使用技术社区实施 SBIRT
  • 批准号:
    10241971
  • 财政年份:
    2018
  • 资助金额:
    $ 64.18万
  • 项目类别:
Scaling up PRIDE Mozambique - Scaling up Partnerships in Research to Implement and Disseminate Sustainable and Scalable Evidence Based Practices in Mozambique
扩大 PRIDE 莫桑比克 - 扩大研究合作伙伴关系,在莫桑比克实施和传播可持续和可扩展的循证实践
  • 批准号:
    10158541
  • 财政年份:
    2017
  • 资助金额:
    $ 64.18万
  • 项目类别:
PRIDE SSA - Partnerships in Research to Implement and Disseminate Sustainable and Scalable Evidence Based Practices in sub-Saharan Africa
PRIDE SSA - 在撒哈拉以南非洲实施和传播可持续和可扩展的循证实践的研究伙伴关系
  • 批准号:
    10158540
  • 财政年份:
    2017
  • 资助金额:
    $ 64.18万
  • 项目类别:
Seeds to PRIDE SSA - Seeds to Partnerships in Research to Implement and Disseminate Sustainable and Scalable Evidence Based Practices in sub-Saharan Africa
Seeds to PRIDE SSA - Seeds to Partnerships in Research 在撒哈拉以南非洲实施和传播可持续和可扩展的基于证据的实践
  • 批准号:
    10158542
  • 财政年份:
    2017
  • 资助金额:
    $ 64.18万
  • 项目类别:
HIV/STI Prevention for Adolescents with Substance Use Disorder in Treatment
治疗中患有药物滥用障碍的青少年的艾滋病毒/性传播感染预防
  • 批准号:
    8677471
  • 财政年份:
    2013
  • 资助金额:
    $ 64.18万
  • 项目类别:
Global Mental Health (GMH) Research Fellowship: Interventions that Make a Difference
全球心理健康 (GMH) 研究奖学金:发挥作用的干预措施
  • 批准号:
    10628942
  • 财政年份:
    2012
  • 资助金额:
    $ 64.18万
  • 项目类别:
Global Mental Health Research Fellowship: Interventions That Make a Difference
全球心理健康研究奖学金:有所作为的干预措施
  • 批准号:
    10189697
  • 财政年份:
    2012
  • 资助金额:
    $ 64.18万
  • 项目类别:

相似海外基金

An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 64.18万
  • 项目类别:
    Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 64.18万
  • 项目类别:
    Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 64.18万
  • 项目类别:
    Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 64.18万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 64.18万
  • 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 64.18万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 64.18万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 64.18万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 64.18万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 64.18万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了